Is a complete FRA/93Z research report available?

No complete published report is available for fra/93Z (FRA/93Z) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/93Z (FRA/93Z)

Frankfurt Stock Exchange: FRA/93Z · EUR

€5.25

-0.25 (-4.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/93Z analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	11.2M
Revenue (ttm)	8M
Net income (ttm)	18M
EPS (ttm)	€9.79
P/E (trailing)	0.6x
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8M
Net income (ttm): 18M
EPS (ttm): €9.79
P/E (trailing): 0.6x
Market cap: 11.2M

All FRA/93Z indicators

Market & fundamental data

Available fields

158

Groups with data

Currency

EUR

Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Austria
Country code	DE
Employees	32
Employees Change	-15%
Employees Change Percent	-31.91
Enterprise value	EUR 21.8M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-31
Market cap	EUR 11.2M
Price	EUR 5.25
Price currency	EUR
Rev Per Employee	248,751.84x
Sic	2834
Symbol	fra/93Z
Website	https://www.marinomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	160.96%
EV Earnings	1.21x
EV/Sales	2.74x
FCF yield	-9.83%
P/B ratio	-1.59x
P/E ratio	0.62x
P/S ratio	1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.32%
EBITDA Margin	0.6%
Gross margin	82.15%
Gross Profit	EUR 6.5M
Gross Profit Growth	537.42%
Gross Profit Growth Q	18.7%
Gross Profit Growth3 Y	40.68%
Net Income	EUR 18M
Pretax Margin	227.69%
Profit Margin	226.36%
Profit Per Employee	EUR 563,071
ROA	-2.33
Roa5y	-19.48
ROCE	-147.9
ROIC	-147

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-72.37%
Cagr3y	-49.03%
Cagr5y	-45.74%
Revenue Growth	66.08x
Revenue Growth Q	-76.89x
Revenue Growth3 Y	-12.16x
Revenue Growth5 Y	-0.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.13
Assets	EUR 6M
Cash	EUR 951,780
Current Assets	EUR 1.4M
Current Liabilities	EUR 5.8M
Debt	EUR 11.6M
Debt EBITDA	EUR 241
Debt FCF	EUR -10.51
Equity	EUR -7M
Interest Coverage	-0.49
Liabilities	EUR 13M
Long Term Assets	EUR 4.5M
Long Term Liabilities	EUR 7.2M
Net Cash	EUR -10.6M
Net Cash By Market Cap	EUR -94.76
Net Debt EBITDA	EUR 221
Tangible Book Value	EUR -7.1M
Tangible Book Value Per Share	EUR -3.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.25
Inventory Turnover	5.27
Net Working Capital	EUR 42,515
Quick ratio	0.22
Working Capital	EUR -4.3M
Working Capital Turnover	EUR -0.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-72.34%
200-day SMA	14.3
3Y total return	-86.76%
50-day SMA	8.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.3%
All Time High	148
All Time High Change	-96.45%
All Time High Date	2021-03-15
All Time Low	2.6
All Time Low Change	101.92%
All Time Low Date	2024-08-16
ATR	0.59
Ch YTD	-70.99
High	5.25
High52	21.1
High52 Date	2025-07-31
High52ch	-75.12%
Low	5.25
Low52	3
Low52 Date	2026-07-17
Low52ch	75%
Ma50ch	-36.07%
Price vs 200-day SMA	-63.3%
RSI	39.39
RSI Monthly	27.49
RSI Weekly	29.24
Sharpe ratio	-0.79x
Sortino ratio	-0.93
Total Return	-3.46%
Tr YTD	-70.89
Tr1m	-36.36%
Tr1w	-6.25%
Tr3m	-58.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -263,877
Operating margin	-3.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,489,930%
Shares Insiders	25.47%
Shares Institutions	9.59%
Shares Qo Q	0%
Shares Yo Y	3.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	199.45x
Bv Per Share	-3.83
Ch1m	-36.36
Ch1w	-6.25
Ch1y	-72.44
Ch3m	-58.98
Ch3y	-86.81
Ch5y	-95.31
Ch6m	-70.42
Change	-4.55%
Change From Open	0
Close	5.5
Days Gap	-4.55
Depreciation Amortization	311,894
Earnings Date	2026-09-16
EBIT	EUR -263,877
EBITDA	EUR 48,017
EPS	EUR 9.79
F Score	4
FCF	EUR -1.1M
FCF EV Yield	-5.05x
Financing CF	300,000
Fiscal Year End	December
Founded	2,006
Income Tax	EUR 106,098
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2025-12-31
Ma150	12.79
Ma150ch	-58.96%
Ma20	6.66
Ma20ch	-21.19%
Net CF	-700,000
Next Earnings Date	2026-09-16
Open	5.25
Ppne	4,506,114
Price Date	2026-07-30
Price EBITDA	EUR 233
Relative Volume	1.31x
Revenue	7,960,059x
Tax By Revenue	1.33x
Tax Rate	0.59%
Tr6m	-70.32%
Volume	0
Z Score	-10.69

FRA/93Z (FRA/93Z)

Coverage state: Market snapshot only — no published research

Generate the first FRA/93Z analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/93Z

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/93Z indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/93Z

Frequently asked questions